2014
DOI: 10.1534/genetics.114.165225
|View full text |Cite
|
Sign up to set email alerts
|

Whole Exome Sequencing of Distant Relatives in Multiplex Families Implicates Rare Variants in Candidate Genes for Oral Clefts

Abstract: A dozen genes/regions have been confirmed as genetic risk factors for oral clefts in human association and linkage studies, and animal models argue even more genes may be involved. Genomic sequencing studies should identify specific causal variants and may reveal additional genes as influencing risk to oral clefts, which have a complex and heterogeneous etiology. We conducted a whole exome sequencing (WES) study to search for potentially causal variants using affected relatives drawn from multiplex cleft famil… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
84
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 85 publications
(86 citation statements)
references
References 21 publications
1
84
0
1
Order By: Relevance
“…Published studies about the implementation of WES as a diagnostic tool have been mostly restricted to specific inbred populations or to particular highly selected groups of patients with homogeneous disease presentations. 5, 6, 7, 8, 9, 10 Here, we present the experience of 1000 consecutive WES requests in our diagnostic clinical routine setup, and validate the use of WES as a first-line diagnostics tool option for patients with a wide range of differential diagnoses or uncharacterized genetic diseases, both in inbred and outbred populations. This comprehensive study includes a highly heterogeneous cohort of 2819 samples from 1000 families referred to us for clinical WES (CentoXome), originating from 54 countries.…”
Section: Introductionmentioning
confidence: 65%
See 1 more Smart Citation
“…Published studies about the implementation of WES as a diagnostic tool have been mostly restricted to specific inbred populations or to particular highly selected groups of patients with homogeneous disease presentations. 5, 6, 7, 8, 9, 10 Here, we present the experience of 1000 consecutive WES requests in our diagnostic clinical routine setup, and validate the use of WES as a first-line diagnostics tool option for patients with a wide range of differential diagnoses or uncharacterized genetic diseases, both in inbred and outbred populations. This comprehensive study includes a highly heterogeneous cohort of 2819 samples from 1000 families referred to us for clinical WES (CentoXome), originating from 54 countries.…”
Section: Introductionmentioning
confidence: 65%
“…To date, reported WES detection rates for deleterious variants in rare disorders encompass 25–30%, but mostly focusing on highly homogenous (geographically or clinically) patient groups. 5, 6, 7, 8, 9, 27, 28, 29 Other studies that used different classification criteria and highly selected phenotypes or populations reported higher numbers, however not adhering the ACMG guidelines that are needed in a clinical setting. 10, 30 …”
Section: Discussionmentioning
confidence: 99%
“…Bureau et al . 42, 43 recently showed how whole exome sequencing (WES) data in distant affected relatives (second-degree and more distant relatives) drawn from multiplex families originally recruited for linkage studies could be used to identify rare variants that modify risk to orofacial clefts. From a long list of candidate genes, this approach identified one novel variant in CHD1 shared by three affected second cousins in a single multiplex family.…”
Section: The Future Challenges: Expanding Into Genomic Sequencingmentioning
confidence: 99%
“…Exome sequencing of second‐ and third‐degree relatives of children with nonsyndromic OFC identified a shared rare damaging mutation in CDH1 (Bureau et al. ). Additional rare mutations using a targeted sequencing approach have been identified in CDH1 , suggesting that it is a nonsyndromic OFC candidate gene (Brito et al.…”
Section: Post‐gwas Eramentioning
confidence: 99%